https://www.selleckchem.com/products/mek162.html
who accounted for three-fifths of patients with TLE, showed a more favorable surgical outcome. The Shexiang Baoxin Pill (MUSKARDIA) has been used for treating coronary artery disease (CAD) and angina for more than 30 years in China. Nevertheless, methodologically sound trials on the use of MUSKARDIA in CAD patients are scarce. The aim of the study is to determine the effects of MUSKARDIA as an add-on to optimal medical therapy (OMT) in patients with stable CAD. A total of 2674 participants with stable CAD from 97 hospitals in China were
Curtir
Comentario
Compartilhar
